应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EQ Equillium Inc.
交易中 07-11 13:25:59 EDT
0.3651
+0.0169
+4.85%
最高
0.3700
最低
0.3378
成交量
16.39万
今开
0.3378
昨收
0.3482
日振幅
9.25%
总市值
1,304万
流通市值
667.85万
总股本
3,572万
成交额
5.95万
换手率
0.90%
流通股本
1,829万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Equillium, Inc.盘中异动 大幅拉升6.26%报0.370美元
市场透视 · 13:38
Equillium, Inc.盘中异动 大幅拉升6.26%报0.370美元
Equillium, Inc.盘中异动 股价大涨5.77%
市场透视 · 07-09 14:12
Equillium, Inc.盘中异动 股价大涨5.77%
Equillium, Inc.盘中异动 下午盘股价大涨5.55%
市场透视 · 07-07
Equillium, Inc.盘中异动 下午盘股价大涨5.55%
Equillium, Inc.股价飙升11.61% 市值涨33.04万美元
市场透视 · 06-30
Equillium, Inc.股价飙升11.61% 市值涨33.04万美元
AMG电动CLA 45 EQ曝光:三轴向磁通电机加持,带主动式后扰流板
市场资讯 · 06-29
AMG电动CLA 45 EQ曝光:三轴向磁通电机加持,带主动式后扰流板
Equillium, Inc.盘中异动 快速跳水6.41%
市场透视 · 06-26
Equillium, Inc.盘中异动 快速跳水6.41%
Equillium, Inc.盘中异动 早盘快速下跌9.11%
市场透视 · 06-25
Equillium, Inc.盘中异动 早盘快速下跌9.11%
Equillium, Inc.盘中异动 早盘股价大涨6.66%报0.309美元
市场透视 · 06-24
Equillium, Inc.盘中异动 早盘股价大涨6.66%报0.309美元
Equillium, Inc.盘中异动 快速下挫5.38%报0.322美元
市场透视 · 06-17
Equillium, Inc.盘中异动 快速下挫5.38%报0.322美元
Equillium, Inc.盘中异动 股价大跌8.18%
市场透视 · 06-13
Equillium, Inc.盘中异动 股价大跌8.18%
Equillium, Inc.盘中异动 股价大涨6.09%报0.410美元
市场透视 · 06-12
Equillium, Inc.盘中异动 股价大涨6.09%报0.410美元
Equillium, Inc.盘中异动 股价大跌7.97%
市场透视 · 06-10
Equillium, Inc.盘中异动 股价大跌7.97%
Equillium, Inc.盘中异动 大幅拉升6.18%
市场透视 · 06-06
Equillium, Inc.盘中异动 大幅拉升6.18%
Equillium, Inc.盘中异动 早盘大幅上涨5.60%
市场透视 · 06-03
Equillium, Inc.盘中异动 早盘大幅上涨5.60%
Equillium, Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 06-02
Equillium, Inc.盘中异动 早盘股价大跌5.00%
Equillium, Inc.股价拉升10.46% 市值涨142.83万美元
市场透视 · 05-30
Equillium, Inc.股价拉升10.46% 市值涨142.83万美元
Equillium, Inc.盘中异动 下午盘股价大涨6.93%
市场透视 · 05-21
Equillium, Inc.盘中异动 下午盘股价大涨6.93%
Equillium, Inc.盘中异动 早盘大幅上涨7.14%报0.411美元
市场透视 · 05-20
Equillium, Inc.盘中异动 早盘大幅上涨7.14%报0.411美元
Equillium, Inc.盘中异动 股价大涨10.16%
市场透视 · 05-19
Equillium, Inc.盘中异动 股价大涨10.16%
Equillium, Inc.盘中异动 快速下跌5.08%
市场透视 · 05-16
Equillium, Inc.盘中异动 快速下跌5.08%
公司概况
公司名称:
Equillium Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Equillium, Inc.于2017年3月16日在特拉华州注册成立,该公司前身为Attenuate Biopharmaceuticals,Inc.。该公司是一家临床阶段的生物技术公司,利用对免疫生物学的深刻理解来开发新的疗法,以治疗具有高度未满足医疗需求的严重自身免疫和炎症,或免疫炎症疾病。公司战略专注于推进候选产品的临床开发,包括潜在地寻求额外的适应症和获得新的候选产品和平台以扩大管道。该公司打算独立或通过合作伙伴关系将候选产品商业化,或通过战略交易将公司管道货币化。
发行价格:
--
{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":0.3651,"timestamp":1752254742139,"preClose":0.3482,"halted":0,"volume":163855,"delay":0,"floatShares":18292151,"shares":35719317,"eps":-0.394659,"marketStatus":"交易中","change":0.0169,"latestTime":"07-11 13:25:59 EDT","open":0.3378,"high":0.37,"low":0.3378,"amount":59453.6659818,"amplitude":0.092476,"askPrice":0.37,"askSize":110,"bidPrice":0.3328,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.394659,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752264000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":0.3482,"preHourTrading":{"tag":"盘前","latestPrice":0.35,"preClose":0.3482,"latestTime":"09:09 EDT","volume":19067,"amount":6580.3229586,"timestamp":1752239346405},"postHourTrading":{"tag":"盘后","latestPrice":0.3299,"preClose":0.3482,"latestTime":"19:58 EDT","volume":5066,"amount":1669.8709,"timestamp":1752191936219},"volumeRatio":0.187036,"impliedVol":0.9832,"impliedVolPercentile":0.428},"requestUrl":"/m/hq/s/EQ/wiki","defaultTab":"wiki","newsList":[{"id":"2550245959","title":"Equillium, Inc.盘中异动 大幅拉升6.26%报0.370美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550245959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550245959?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:38","pubTimestamp":1752241137,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时38分,Equillium, Inc.股票出现异动,股价大幅拉升6.26%。截至发稿,该股报0.370美元/股,成交量9.0443万股,换手率0.25%,振幅3.48%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071121385897a2610e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071121385897a2610e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2550655700","title":"Equillium, Inc.盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550655700?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:12","pubTimestamp":1752070376,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分,Equillium, Inc.股票出现异动,股价大幅上涨5.77%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为1.31%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2549557730","title":"Equillium, Inc.盘中异动 下午盘股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557730","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549557730?lang=zh_cn&edition=full","pubTime":"2025-07-08 03:26","pubTimestamp":1751916394,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日03时26分,Equillium, Inc.股票出现异动,股价快速上涨5.55%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708032634979d5f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708032634979d5f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"2547018875","title":"Equillium, Inc.股价飙升11.61% 市值涨33.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547018875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547018875?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:19","pubTimestamp":1751293190,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时19分,Equillium, Inc.股票出现异动,股价快速拉升11.61%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063022195095315cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063022195095315cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2547108594","title":"AMG电动CLA 45 EQ曝光:三轴向磁通电机加持,带主动式后扰流板","url":"https://stock-news.laohu8.com/highlight/detail?id=2547108594","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547108594?lang=zh_cn&edition=full","pubTime":"2025-06-29 16:45","pubTimestamp":1751186700,"startTime":"0","endTime":"0","summary":"IT之家注意到,梅赛德斯-AMG 的电动 CLA 45 在最近的纽博格林测试中揭开了部分伪装,尽管 CLA 45 EQ 不如其“大哥”那么奢华,但其仍将具备一些类似的性能特性,包括一个主动式后扰流板。非 AMG 版的 CLA 车型配备了 800 伏快速充电系统,但目前无法使用 400 伏充电站。不过,梅赛德斯有望在明年解决这一不合理的情况,因此 CLA 45 EQ 的车主将拥有更多的充电选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-06-29/doc-infctqvq5455085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AMG","BK4568","EQ","BK4505","BK4135","BK4139"],"gpt_icon":0},{"id":"2546316977","title":"Equillium, Inc.盘中异动 快速跳水6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546316977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546316977?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:56","pubTimestamp":1750946162,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时56分,Equillium, Inc.股票出现异动,股价急速跳水6.41%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262156029790058e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262156029790058e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568","VOR"],"gpt_icon":0},{"id":"2546426245","title":"Equillium, Inc.盘中异动 早盘快速下跌9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546426245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546426245?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:33","pubTimestamp":1750858436,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时33分,Equillium, Inc.股票出现波动,股价大幅跳水9.11%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213356a71d26f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213356a71d26f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2545233206","title":"Equillium, Inc.盘中异动 早盘股价大涨6.66%报0.309美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545233206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545233206?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:33","pubTimestamp":1750771982,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时33分,Equillium, Inc.股票出现异动,股价大幅上涨6.66%。截至发稿,该股报0.309美元/股,成交量7.8245万股,换手率0.22%,振幅0.00%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213302a71b557e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213302a71b557e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"2544998129","title":"Equillium, Inc.盘中异动 快速下挫5.38%报0.322美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544998129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544998129?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:39","pubTimestamp":1750167589,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时39分,Equillium, Inc.股票出现波动,股价快速下跌5.38%。截至发稿,该股报0.322美元/股,成交量10.8119万股,换手率0.30%,振幅3.50%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.67%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506172139499520482c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506172139499520482c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"2543568013","title":"Equillium, Inc.盘中异动 股价大跌8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543568013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543568013?lang=zh_cn&edition=full","pubTime":"2025-06-13 21:33","pubTimestamp":1749821611,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日21时33分,Equillium, Inc.股票出现异动,股价急速跳水8.18%。截至发稿,该股报0.355美元/股,成交量50.1892万股,换手率1.41%,振幅1.66%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213331a707a1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213331a707a1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"2542108095","title":"Equillium, Inc.盘中异动 股价大涨6.09%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542108095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542108095?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:32","pubTimestamp":1749735150,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时32分,Equillium, Inc.股票出现异动,股价大幅拉升6.09%。截至发稿,该股报0.410美元/股,成交量1047.67万股,换手率29.33%,振幅3.19%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213230a4a54662&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213230a4a54662&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2542348215","title":"Equillium, Inc.盘中异动 股价大跌7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542348215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542348215?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:47","pubTimestamp":1749563236,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时47分,Equillium, Inc.股票出现异动,股价急速下挫7.97%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610214717a7023d32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610214717a7023d32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2541863302","title":"Equillium, Inc.盘中异动 大幅拉升6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863302?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:31","pubTimestamp":1749216715,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时31分,Equillium, Inc.股票出现异动,股价急速上涨6.18%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213156a6fd4a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213156a6fd4a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"2540377059","title":"Equillium, Inc.盘中异动 早盘大幅上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540377059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540377059?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:24","pubTimestamp":1748960657,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时24分,Equillium, Inc.股票出现异动,股价快速拉升5.60%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603222417977002ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603222417977002ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2540579625","title":"Equillium, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540579625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540579625?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:48","pubTimestamp":1748872081,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时48分,Equillium, Inc.股票出现异动,股价快速跳水5.00%。截至发稿,该股报0.371美元/股,成交量2788股,换手率0.01%,振幅0.00%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214801a6f727ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214801a6f727ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2539527886","title":"Equillium, Inc.股价拉升10.46% 市值涨142.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539527886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539527886?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:33","pubTimestamp":1748612010,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时33分,Equillium, Inc.股票出现波动,股价急速上涨10.46%。截至发稿,该股报0.382美元/股,成交量2269股,换手率0.01%,振幅0.40%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为3.41%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213330a492efb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213330a492efb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"2537581889","title":"Equillium, Inc.盘中异动 下午盘股价大涨6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537581889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537581889?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:22","pubTimestamp":1747848168,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时22分,Equillium, Inc.股票出现异动,股价快速上涨6.93%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012248aa2c95c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012248aa2c95c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2536164999","title":"Equillium, Inc.盘中异动 早盘大幅上涨7.14%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536164999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536164999?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:57","pubTimestamp":1747753033,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时57分,Equillium, Inc.股票出现波动,股价大幅拉升7.14%。截至发稿,该股报0.411美元/股,成交量2301股,换手率0.01%,振幅4.56%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052022571394fcd512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052022571394fcd512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4082","NRXS","EQ"],"gpt_icon":0},{"id":"2536068712","title":"Equillium, Inc.盘中异动 股价大涨10.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536068712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536068712?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:31","pubTimestamp":1747661485,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时31分,Equillium, Inc.股票出现异动,股价急速上涨10.16%。截至发稿,该股报0.412美元/股,成交量5110股,换手率0.01%,振幅0.00%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213126975e6443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213126975e6443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2535118133","title":"Equillium, Inc.盘中异动 快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535118133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535118133?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:33","pubTimestamp":1747405998,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时33分,Equillium, Inc.股票出现波动,股价快速跳水5.08%。Equillium, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516223318aa2c916c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516223318aa2c916c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":0.0847},{"period":"1month","weight":-0.0068},{"period":"3month","weight":-0.2731},{"period":"6month","weight":-0.503},{"period":"1year","weight":-0.5243},{"period":"ytd","weight":-0.5346}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Equillium, Inc.于2017年3月16日在特拉华州注册成立,该公司前身为Attenuate Biopharmaceuticals,Inc.。该公司是一家临床阶段的生物技术公司,利用对免疫生物学的深刻理解来开发新的疗法,以治疗具有高度未满足医疗需求的严重自身免疫和炎症,或免疫炎症疾病。公司战略专注于推进候选产品的临床开发,包括潜在地寻求额外的适应症和获得新的候选产品和平台以扩大管道。该公司打算独立或通过合作伙伴关系将候选产品商业化,或通过战略交易将公司管道货币化。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.074209},{"month":2,"riseRate":0.571429,"avgChangeRate":0.328463},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.190483},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.137456},{"month":5,"riseRate":0.714286,"avgChangeRate":0.036577},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.151956},{"month":7,"riseRate":0.571429,"avgChangeRate":0.309767},{"month":8,"riseRate":0.666667,"avgChangeRate":0.073981},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.069941},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.079943},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.050609},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.119129}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}